tegoprazan
Commercial- Indications
- Gastroesophageal reflux disease, Gastric ulcer, Helicobacter pylori infection, Chronic atrophic gastritis
Company intelligence / Profile preview
Carnot Laboratorios has over eight decades of experience developing and commercializing pharmaceutical products for Latin America. The company focuses on innovative medicines for common ailments across several therapeutic areas including gastroenterology and respiratory disease. It operates two production facilities in Mexico and exports to more than fifteen countries. Recent investments include a new state-of-the-art manufacturing plant in Hidalgo to expand capacity and global reach.[5] No recent clinical trial results are publicly highlighted.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Carnot Laboratorios.